Cencora Analyst Ratings
JPMorgan Adjusts Price Target on Cencora to $287 From $280, Maintains Overweight Rating
Evercore ISI Adjusts Price Target on Cencora to $260 From $270, Maintains Outperform Rating
Argus Research Keeps Their Buy Rating on Cencora (COR)
A Quick Look at Today's Ratings for Cencora(COR.US), With a Forecast Between $242 to $287
Analysts Conflicted on These Healthcare Names: Cencora (COR), Schrodinger (SDGR) and Biogen (BIIB)
A Quick Look at Today's Ratings for Cencora(COR.US), With a Forecast Between $249 to $287
Cencora Analyst Ratings
Analysts Have Conflicting Sentiments on These Healthcare Companies: Raffles Medical Group (OtherRAFLF), Cencora (COR) and Acadia Healthcare (ACHC)
Cencora's Resilient Growth and Strong Walgreens Alliance Affirm Buy Rating
Citigroup Adjusts Price Target on Cencora to $284 From $280
Evercore Maintains Cencora(COR.US) With Buy Rating, Raises Target Price to $260
Deutsche Bank Adjusts Price Target on Cencora to $247 From $262, Maintains Buy Rating
Barclays Sticks to Its Buy Rating for Cencora (COR)
Cencora Analyst Ratings
Cencora Analyst Ratings
Analysts Are Bullish on Top Healthcare Stocks: Teva Pharmaceutical (TEVA), Cencora (COR)
Analysts' Top Healthcare Picks: Inspire Medical Systems (INSP), Cencora (COR)
JPMorgan Adjusts Price Target on Cencora to $280 From $270
Jefferies Adjusts Price Target on Cencora to $230 From $235